Cargando…

All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing

The conversion rate between asymptomatic infections and reported/unreported symptomatic infections is a very sensitive parameter for model variables that spread COVID-19. This is important information for follow-up use in screening, prediction, prognostics, contact tracing, and drug development for...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xian-Xian, Yang, Jie, Fong, Simon, Dey, Nilanjan, Millham, Richard C., Fiaidhi, Jinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518365/
https://www.ncbi.nlm.nih.gov/pubmed/36078679
http://dx.doi.org/10.3390/ijerph191710959
_version_ 1784799165403889664
author Liu, Xian-Xian
Yang, Jie
Fong, Simon
Dey, Nilanjan
Millham, Richard C.
Fiaidhi, Jinan
author_facet Liu, Xian-Xian
Yang, Jie
Fong, Simon
Dey, Nilanjan
Millham, Richard C.
Fiaidhi, Jinan
author_sort Liu, Xian-Xian
collection PubMed
description The conversion rate between asymptomatic infections and reported/unreported symptomatic infections is a very sensitive parameter for model variables that spread COVID-19. This is important information for follow-up use in screening, prediction, prognostics, contact tracing, and drug development for the COVID-19 pandemic. The model described here suggests that there may not be enough researchers to solve all of these problems thoroughly and effectively, and it requires careful selection of what we are doing and rapid sharing of results and models and optimizing modeling simulations with value to reduce the impact of COVID-19. Exploring simulation modeling will help decision makers make the most informed decisions. In order to fight against the “Delta” virus, the establishment of a line of defense through all-people testing (APT) is not only an effective method summarized from past experience but also one of the best means to effectively cut the chain of epidemic transmission. The effect of large-scale testing has been fully verified in the international community. We developed a practical dynamic infectious disease model-SETPG (A + I) RD + APT by considering the effects of the all-people test (APT). The model is useful for studying effects of screening measures and providing a more realistic modelling with all-people-test strategies, which require everybody in a population to be tested for infection. In prior work, a total of 370 epidemic cases were collected. We collected three kinds of known cases: the cumulative number of daily incidences, daily cumulative recovery, and daily cumulative deaths in Hong Kong and the United States between 22 January 2020 and 13 November 2020 were simulated. In two essential strategies of the integrated SETPG (A + I) RD + APT model, comparing the cumulative number of screenings in derivative experiments based on daily detection capability and tracking system application rate, we evaluated the performance of the timespan required for the basic regeneration number (R0) and real-time regeneration number (R0t) to reach 1; the optimal policy of each experiment is available, and the screening effect is evaluated by screening performance indicators. with the binary encoding screening method, the number of screenings for the target population is 8667 in HK and 1,803,400 in the U.S., including 6067 asymptomatic cases in HK and 1,262,380 in the U.S. as well as 2599 cases of mild symptoms in HK and 541,020 in the U.S.; there were also 8.25 days of screening timespan in HK and 9.25 days of screening timespan required in the U.S. and a daily detectability of 625,000 cases in HK and 6,050,000 cases in the U.S. Using precise tracking technology, number of screenings for the target population is 6060 cases in HK and 1,766,420 cases in the U.S., including 4242 asymptomatic cases in HK and 1,236,494 cases in the U.S. as well as 1818 cases of mild symptoms in HK and 529,926 cases in the U.S. Total screening timespan (TS) is 8.25~9.25 days. According to the proposed infectious dynamics model that adapts to the all-people test, all of the epidemic cases were reported for fitting, and the result seemed more reasonable, and epidemic prediction became more accurate. It adapted to densely populated metropolises for APT on prevention.
format Online
Article
Text
id pubmed-9518365
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95183652022-09-29 All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing Liu, Xian-Xian Yang, Jie Fong, Simon Dey, Nilanjan Millham, Richard C. Fiaidhi, Jinan Int J Environ Res Public Health Article The conversion rate between asymptomatic infections and reported/unreported symptomatic infections is a very sensitive parameter for model variables that spread COVID-19. This is important information for follow-up use in screening, prediction, prognostics, contact tracing, and drug development for the COVID-19 pandemic. The model described here suggests that there may not be enough researchers to solve all of these problems thoroughly and effectively, and it requires careful selection of what we are doing and rapid sharing of results and models and optimizing modeling simulations with value to reduce the impact of COVID-19. Exploring simulation modeling will help decision makers make the most informed decisions. In order to fight against the “Delta” virus, the establishment of a line of defense through all-people testing (APT) is not only an effective method summarized from past experience but also one of the best means to effectively cut the chain of epidemic transmission. The effect of large-scale testing has been fully verified in the international community. We developed a practical dynamic infectious disease model-SETPG (A + I) RD + APT by considering the effects of the all-people test (APT). The model is useful for studying effects of screening measures and providing a more realistic modelling with all-people-test strategies, which require everybody in a population to be tested for infection. In prior work, a total of 370 epidemic cases were collected. We collected three kinds of known cases: the cumulative number of daily incidences, daily cumulative recovery, and daily cumulative deaths in Hong Kong and the United States between 22 January 2020 and 13 November 2020 were simulated. In two essential strategies of the integrated SETPG (A + I) RD + APT model, comparing the cumulative number of screenings in derivative experiments based on daily detection capability and tracking system application rate, we evaluated the performance of the timespan required for the basic regeneration number (R0) and real-time regeneration number (R0t) to reach 1; the optimal policy of each experiment is available, and the screening effect is evaluated by screening performance indicators. with the binary encoding screening method, the number of screenings for the target population is 8667 in HK and 1,803,400 in the U.S., including 6067 asymptomatic cases in HK and 1,262,380 in the U.S. as well as 2599 cases of mild symptoms in HK and 541,020 in the U.S.; there were also 8.25 days of screening timespan in HK and 9.25 days of screening timespan required in the U.S. and a daily detectability of 625,000 cases in HK and 6,050,000 cases in the U.S. Using precise tracking technology, number of screenings for the target population is 6060 cases in HK and 1,766,420 cases in the U.S., including 4242 asymptomatic cases in HK and 1,236,494 cases in the U.S. as well as 1818 cases of mild symptoms in HK and 529,926 cases in the U.S. Total screening timespan (TS) is 8.25~9.25 days. According to the proposed infectious dynamics model that adapts to the all-people test, all of the epidemic cases were reported for fitting, and the result seemed more reasonable, and epidemic prediction became more accurate. It adapted to densely populated metropolises for APT on prevention. MDPI 2022-09-02 /pmc/articles/PMC9518365/ /pubmed/36078679 http://dx.doi.org/10.3390/ijerph191710959 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Xian-Xian
Yang, Jie
Fong, Simon
Dey, Nilanjan
Millham, Richard C.
Fiaidhi, Jinan
All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title_full All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title_fullStr All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title_full_unstemmed All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title_short All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing
title_sort all-people-test-based methods for covid-19 infectious disease dynamics simulation model: towards citywide covid testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518365/
https://www.ncbi.nlm.nih.gov/pubmed/36078679
http://dx.doi.org/10.3390/ijerph191710959
work_keys_str_mv AT liuxianxian allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting
AT yangjie allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting
AT fongsimon allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting
AT deynilanjan allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting
AT millhamrichardc allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting
AT fiaidhijinan allpeopletestbasedmethodsforcovid19infectiousdiseasedynamicssimulationmodeltowardscitywidecovidtesting